BNGO News and Press, Bionano Genomics Inc. From 03/03/22

SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of N x Clincial™, a leading software solution for visualization, interpretation and reporting of genomi...

Karyopharm Therapeutics (NASDAQ:KPTI) -29% after US Regulatory update on Selinexor in advanced or recurrent endometrial cancer. GoHealth (NASDAQ:GOCO) -24% on expecting Q4 revenue below estimates. Bright Health (NYSE:BHG) -10% on Q4 earnings release. Telefonaktie...

Image source: The Motley Fool. Bionano Genomics, Inc (NASDAQ: BNGO) Q4 2021 Earnings Call Mar 01, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Bionano Genomics, Inc (BNGO) Q4 2021 Earnings Call Transcript

Bionano Genomics, Inc. (BNGO) Q4 2021 Earnings Conference Call March 1, 2022 4:30 PM ET Company Participants Amy Conrad – Investor Relations Erik Holmlin – Chief Executive Officer Chris Stewart – Chief Financial Officer Conference Call Participants Sung Ji Nam – BT...

Bionano Genomics (NASDAQ:BNGO), a provider of optical genome mapping (OGM) solutions, is trading lower in the post-market Tuesday after the company topped analyst forecasts for revenue with its Q4 2021 financials. While total revenue for the quarter reached $6.3M, the ~58% YoY growth ind...

Bionano Genomics press release (NASDAQ:BNGO): Q4 Net Loss -$22.95M, compared to -$11.73M in Q4 2020. Revenue of $6.3M beats by $0.45M. Revenue was $18.0 million for the full year and $6.3 million for the fourth quarter of 2021, representing 111% and 58% increases over the corresponding period...

Full-year 2021 revenue growth of 111% over 2020 Achieved publicly announced anticipated milestones for 2021 Strong balance sheet with $250.6 million in cash, cash equivalents, and available-for-sale securities as of YE 2021 Conference call today, March 1 ...

Rare diseases affect more than 350 million people globally It is estimated that 1 in 15 people globally are affected by a rare disease Estimates are that 25 million Americans and 30 million in Europe are living with a rare disease More than 7,000 rare diseases ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics  (NASDAQ: BNGO ) is a life sciences instrumentation company focused on the genome analysis space. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. Sour...

SAN DIEGO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 1 st , 2022 at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and year end 2021 and to hig...